Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.55 USD | +1.04% | -9.18% | -35.45% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 63% by 2026.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The company appears highly valued given the size of its balance sheet.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-35.45% | 558M | B- | ||
+75.35% | 12.55B | B- | ||
-23.01% | 7.51B | C+ | ||
+8.35% | 6.74B | C- | ||
+14.40% | 5.47B | D+ | ||
+32.74% | 4.74B | - | ||
-14.85% | 4.89B | B | ||
-25.57% | 3.7B | B- | ||
-23.06% | 2.9B | C | ||
+55.06% | 2.49B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SIBN Stock
- Ratings SI-BONE, Inc.